Personal Initiative. Dynamic Pace. Meaningful Work.
Novo Holdings to Acquire Catalent
CDMOs’ Critical Role in a Rapidly Evolving Biopharma Landscape
Watch this on-demand webinar to hear from President & CEO, Alessandro Maselli, as he discusses the evolving role of CDMOs, and what's next as Catalent shifts from public to private ownership under it's previously announced transaction with Novo Holdings.
Who We AreCatalent is a global company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide.
We Are GlobalWith sites throughout North America, Europe, Latin America and Asia Pacific, there are endless opportunities for growth, development and global exposure. Connect with our global network across multiple continents today!
Our diverse team works together in support of our mission to help people live better, healthier lives. If you want the opportunity to take personal initiative, work at a dynamic pace and positively impact the lives of millions of people across the globe, JOIN US!
Catalent fosters an environment in which individuals are respected, where differences and similarities are valued, and where everyone has opportunities to succeed. We strive to build a diverse and inclusive workplace.
At Catalent, responsibility and sustainability are integrated into the heart of our business. We have a global network of over 45 community ambassadors who organize various fundraisers and volunteer events throughout the year.